Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma
The treatment landscape for lymphoma and multiple myeloma, which disproportionally affect older adults, has been transformed by the advent of T cell-mediated immunotherapies, including immune checkpoint inhibition, T cell-engaging bispecific antibodies, and chimeric antigen receptor (CAR) T cell the...
Saved in:
| Main Authors: | Tamas Fulop, Abdullah M Khan, Valentín Ortiz-Maldonado, Marcus Vetter, Rainer Wirth, Fabian Ullrich, Paul J Bröckelmann, Amin T Turki, Elena-Diana Chiru, Bastian von Tresckow, Raul Cordoba, Nina Rosa Neuendorff |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/12/e009462.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Capivasertib After Progression on CDK4/6 Inhibitor Combined with Endocrine Therapy in a Patient with HR-Positive, HER2-Negative Metastatic Breast Cancer: A Case Report
by: Diana Chiru, et al.
Published: (2024-12-01) -
Benefits and Applications of Oncotype DX Breast Recurrence Score Testing among Breast Cancer Patients: Current Recommendations and Controversies.
by: Elena-Diana Chiru, et al.
Published: (2023-06-01) -
Long non-coding RNA LINC00926 is a biomarker for naïve B-cells with prognostic value in advanced stage classic Hodgkin Lymphoma
by: Ingram Iaccarino, et al.
Published: (2025-07-01) -
Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma
by: I. O. Stoma
Published: (2021-01-01) -
Maximizing the Benefit of CAR T-Cell Therapy in Lymphoma and Multiple Myeloma
by: Federico Simonetta
Published: (2022-10-01)